New oral pill options include Amycretin, which contains GLP-1 and amylin, and Conveglipron, a new oral GLP-1 similar to Foundayo, which is currently in Phase 2-3 trials
Check your specific plans formulary
Its cardiovascular safety in patients with cardiovascular disease or high cardiovascular risk was demonstrated in the aforementioned PIONEER-6 study.62 In the PIONEER 5 study, in patients with CKD stage 3, it was evaluated the efficacy and safety of a 14 mg dose, resulting superior to placebo in terms of reduction of HbA1c (-0.8% vs
however, patients should continue to take GLP-1 medications since the benefits in preserving microvascular and cardiovascular health outweigh the risks of EWDR
Among 79 websites marketing compounded GLP-1s or prescriptions for them, 37% stated or implied that the drugs were FDA-approved
Lopez seems to agree